AI-generated analysis. Always verify with the original filing.
On March 9, 2026, MiniMed Group, Inc. completed its previously announced merger with KH2, incorporating Item 1.01 disclosures into Items 2.01 and 3.02, while KH2 entered a financial obligation on January 15, 2026 under Item 2.03 and the Company amended its Certificate of Incorporation on March 6, 2026 under Item 5.03.
Event Type
Disclosure
Mandatory
Variant
8-K
. Entry into a Material Definitive Agreement. On March 9, 2026, MiniMed Group, Inc., a Delaware corporation (the “ Company ”), completed its previously announce
. Completion of Acquisition or Disposition of Assets. The description of the Company’s merger with KH2 set forth under Item 1.01 above is incorporated herein by
. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. On January 15, 2026, KH2 entered into a cre
. Unregistered Sales of Equity Securities. The information set forth under Item 1.01 above is incorporated herein by reference. Item 3.03. Material Modification
. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Amendment and Restatement of Certificate of Incorporation On March 6, 2026, the Comp
(including Exhibit 99.1) shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 3.1 Second Amended and Restated Certificate of Incorporation of MiniMed Group, Inc. 3.2